C4951004 - BHV3000-406: a Phase 4, Randomized, Double-blind Placebo Controlled, Efficacy and Tolerability Trial of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

Authors
Category Primary study
Registry of TrialsClinical Trials Information System
Year 2024
To compare the efficacy of rimegepant with placebo in the acute treatment of migraine, as measured by migraine headache pain relief at 2 hours postdose during the DBT Phase.
Epistemonikos ID: fa0138714804ffe5efbcf3f7e0483994dccb4c91
First added on: Dec 06, 2024